Now, if you compare what you thought the disease was when you started with how you see it today, what has changed most fundamentally?

Yeah, thank you, Nicole.

First of all, I'm really extremely humbled and honored to deliver the uRetina lecture this year, 2026, in Vienna.

And I've chosen the topic of dry AMD, as a matter of fact, as you very elegantly introduced.

It's quite something just for some time.

And it was really triggered with my two-year fellowship with Alan Bird at the time.

In London, at this time, AMD was really not a hot topic in retina.

So when you first started looking at autofluorescence patterns around geographic atrophy, and I just want to mention the FAM study, for example, did you already realize that you were looking at areas that might predict where atrophy would develop next?